283 related articles for article (PubMed ID: 30085294)
21. Toxicological evaluation of smokeless tobacco: 2-year chronic toxicity and carcinogenicity feeding study in Wistar Han rats.
Theophilus EH; Hayes JR; Ayres PH; Morgan WT; Potts RJ; Garner CD; Fallacara DM; Hejtmancik MR; Singer AW
Exp Toxicol Pathol; 2015 Oct; 67(10):539-50. PubMed ID: 26382975
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation Of A Discriminatory Dissolution Method for Portioned Moist Snuff and Snus.
Rahman Z; Mohamed EM; Dharani S; Khuroo T; Young M; Feng C; Cecil T; Khan MA
J Pharm Sci; 2022 Jun; 111(6):1700-1708. PubMed ID: 34861248
[TBL] [Abstract][Full Text] [Related]
23. An in Vitro Study of Constituents Released from Smokeless Tobacco Products into Human Saliva.
Guan S; Bush L; Ji H
J Anal Toxicol; 2022 Jul; 46(6):625-632. PubMed ID: 34155520
[TBL] [Abstract][Full Text] [Related]
24. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
25. In vitro study of nicotine release from smokeless tobacco.
Nasr MM; Reepmeyer JC; Tang Y
J AOAC Int; 1998; 81(3):540-3. PubMed ID: 9606918
[TBL] [Abstract][Full Text] [Related]
26. [Measurement of Nicotine, Tobacco-Specific Nitrosamines, and Additives in the Filler and Gas from Japanese Brand Snuff].
Inaba Y; Utsugi R; Ohkubo T; Uchiyama S; Ohta T; Kunugita N
Nihon Eiseigaku Zasshi; 2016; 71(1):76-83. PubMed ID: 26832620
[TBL] [Abstract][Full Text] [Related]
27. Daily use of smokeless tobacco: systemic effects.
Benowitz NL; Jacob P; Yu L
Ann Intern Med; 1989 Jul; 111(2):112-6. PubMed ID: 2742246
[TBL] [Abstract][Full Text] [Related]
28. The composition of contemporary American and Swedish smokeless tobacco products.
McAdam KG; Kimpton H; Faizi A; Porter A; Rodu B
BMC Chem; 2019 Dec; 13(1):31. PubMed ID: 31384779
[TBL] [Abstract][Full Text] [Related]
29. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
[TBL] [Abstract][Full Text] [Related]
30. Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation.
Harris AC; Tally L; Schmidt CE; Muelken P; Stepanov I; Saha S; Vogel RI; LeSage MG
Drug Alcohol Depend; 2015 Feb; 147():60-7. PubMed ID: 25561387
[TBL] [Abstract][Full Text] [Related]
31. The Swedish snus and the Sudanese toombak: are they different?
Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
[TBL] [Abstract][Full Text] [Related]
32. Smokeless tobacco, sport and the heart.
Chagué F; Guenancia C; Gudjoncik A; Moreau D; Cottin Y; Zeller M
Arch Cardiovasc Dis; 2015 Jan; 108(1):75-83. PubMed ID: 25497687
[TBL] [Abstract][Full Text] [Related]
33. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
[TBL] [Abstract][Full Text] [Related]
34. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
[TBL] [Abstract][Full Text] [Related]
35. Characterising advertising strategies and expenditures for conventional and newer smokeless tobacco products.
Emery SL; Binns S; Carter CC; Rose SW; Kostygina G
Tob Control; 2023 Nov; 32(6):795-798. PubMed ID: 35803674
[TBL] [Abstract][Full Text] [Related]
36. Factors effecting the induction of rat forestomach hyperplasia induced by Swedish oral smokeless tobacco (snus).
Joksić G; Rutqvist LE; Mićić M; Tričković JF; Nilsson R
Regul Toxicol Pharmacol; 2019 Jun; 104():21-28. PubMed ID: 30844416
[TBL] [Abstract][Full Text] [Related]
37. Smokeless tobacco products harbor diverse bacterial microbiota that differ across products and brands.
Smyth EM; Kulkarni P; Claye E; Stanfill S; Tyx R; Maddox C; Mongodin EF; Sapkota AR
Appl Microbiol Biotechnol; 2017 Jul; 101(13):5391-5403. PubMed ID: 28432442
[TBL] [Abstract][Full Text] [Related]
38. The pH of Smokeless Tobacco Determines Nicotine Buccal Absorption: Results of a Randomized Crossover Trial.
Wilhelm J; Mishina E; Viray L; Paredes A; Pickworth WB
Clin Pharmacol Ther; 2022 May; 111(5):1066-1074. PubMed ID: 34826137
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity and specificity of a reagent-impregnated test strip in identifying smokeless tobacco users.
Glover ED; Glover PN; Laflin MT; Nochur SV; Strnad JV
Nicotine Tob Res; 2007 Apr; 9(4):499-503. PubMed ID: 17454705
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
